Evolent Health Inc
NYSE:EVH

Watchlist Manager
Evolent Health Inc Logo
Evolent Health Inc
NYSE:EVH
Watchlist
Price: 2.95 USD -4.84%
Market Cap: $329.3m

EV/OCF

29.6
Current
1%
More Expensive
vs 3-y average of 29.2

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
29.6
=
Enterprise Value
$1.1B
/
Operating Cash Flow
$38.8m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
29.6
=
Enterprise Value
$1.1B
/
Operating Cash Flow
$38.8m

Valuation Scenarios

Evolent Health Inc is trading above its 3-year average

If EV/OCF returns to its 3-Year Average (29.2), the stock would be worth $2.92 (1% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-44%
Maximum Upside
No Upside Scenarios
Average Downside
21%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 29.6 $2.95
0%
3-Year Average 29.2 $2.92
-1%
5-Year Average 29.2 $2.92
-1%
Industry Average 18.7 $1.86
-37%
Country Average 16.7 $1.67
-44%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
US
Evolent Health Inc
NYSE:EVH
329.3m USD 29.6 -0.6
US
Cerner Corp
LSE:0R00
31.3B USD 18.9 53.1
US
Veeva Systems Inc
NYSE:VEEV
25.6B USD 13.6 28.5
AU
Pro Medicus Ltd
ASX:PME
14.8B AUD 111.5 61.7
JP
M3 Inc
TSE:2413
1T JPY 13.6 20.5
SE
Sectra AB
STO:SECT B
51.8B SEK 63.2 96.4
US
Waystar Holding Corp
NASDAQ:WAY
4.8B USD 19.5 41.5
US
Doximity Inc
NYSE:DOCS
4.3B USD 11.4 18
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.3B CNY 38.2 -62.7
US
Vocera Communications Inc
F:V00
2.4B EUR 61.3 -328
US
Heartflow Inc
NASDAQ:HTFL
2.7B USD 0 0
P/E Multiple
Earnings Growth PEG
US
Evolent Health Inc
NYSE:EVH
Average P/E: 45.7
Negative Multiple: -0.6
N/A N/A
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
28.5
25%
1.1
AU
Pro Medicus Ltd
ASX:PME
61.7
29%
2.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
96.4
14%
6.9
US
W
Waystar Holding Corp
NASDAQ:WAY
41.5
55%
0.8
US
Doximity Inc
NYSE:DOCS
18
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -62.7
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A

Market Distribution

Higher than 81% of companies in the United States of America
Percentile
81th
Based on 9 518 companies
81th percentile
29.6
Low
0 — 11.7
Typical Range
11.7 — 23.6
High
23.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 11.7
Median 16.7
70th Percentile 23.6
Max 3 178 983.5

Evolent Health Inc
Glance View

Evolent Health Inc. emerged in 2011 from a collaboration between The Advisory Board Company and the University of Pittsburgh Medical Center, with a mission to reshape healthcare delivery in the United States. As the healthcare landscape shifted towards value-based care models, where providers are compensated for keeping patients healthy rather than on the volume of services delivered, Evolent positioned itself as a pivotal partner for healthcare systems aiming to transition smoothly into this new paradigm. The company's core offerings revolve around its technology-driven platform, which integrates data analytics, care management, and clinical expertise to enable healthcare providers and payers to deliver more efficient and patient-centric care. By providing these services, Evolent helps its clients reduce costs and improve patient outcomes, thus thriving in a rapidly evolving industry. From a business perspective, Evolent Health generates revenue primarily through two streams: provider services and performance-based contracts. For its provider services, Evolent signs agreements with healthcare providers, offering them proprietary technology and consulting services, all designed to enhance their operational efficiency and clinical capabilities. The performance-based contracts, which are fundamental in a value-based care environment, allow Evolent to share in the financial benefits realized by its clients from improved patient care and cost savings. This model not only aligns Evolent's success with that of its clients but also positions the company at the heart of the healthcare value chain, asserting its influence through partnerships that are financially symbiotic.

EVH Intrinsic Value
19.72 USD
Undervaluation 85%
Intrinsic Value
Price $2.95
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett